Realbotix Corp. XBOTF

SRX Global Inc. adds Onconetix (ONCO) to its portfolio and updates shareholders on liquidating positions in Vistagen Therapeutics (VTGN) and Greenland Mines (GRML). Onconetix previously announced an agreement to acquire Realbotix LLC. The Realbotix system, built around Vinci AI Vision, embeds cameras and tracking lenses in robot eyeballs to detect motion, recognize returning users, and identify objects/colors; it uses in-eye sensors to gauge micro-expressions and adapt conversations via LLMs. SRX says the ONCO investment anticipates the Realbotix acquisition closing and sees Vinci as undervalued with potential defense applications ranging from drones with facial recognition to body-camera use. The press release also reiterates forward-looking statements and outlines risks, urging investors to review SEC filings. Planned acquisition by Onconetix could materially redefine Realbotix's ownership and strategic direction if closed.

Onconetix provides strategic bridge financing to Realbotix LLC in support of pending acquisition. Bridge financing for pending acquisition marks major strategic move with strong potential to alter company trajectory and investor sentiment.

Realbotix, an Onconetix acquisition target, launches a pilot with a leading European telecommunications company to deploy humanoid robots in live presentations and events. Pilot deployment with major telecom expands Realbotix humanoid robot use into events and presentations, likely boosting revenue and visibility.

Realbotix partners with a European telecom company to launch a pilot expanding robot capabilities for live presentations and events. Pilot expands Realbotix robot uses into live events and presentations with moderate innovation upside.

Realbotix Corp. (XBOTF) released its financial results for Q3-2026. Quarterly financial results release supplies performance data that can shift near-term investor views and valuation without indicating major strategic shifts.

Realbotix partners with Bloom to launch UK pilot deploying humanoid robots against elderly social isolation. Partnership launches UK pilot expanding humanoid robot use into elderly care and opening new market segment.

Realbotix partners with Bloom Services to launch UK pilot deploying humanoid robots against elderly social isolation, as highlighted by Onconetix. Realbotix initiates UK pilot project with humanoid robots for elderly care through new partnership.

Realbotix launches humanoid robot and AI teacher's assistant pilot program in New York State school district. Humanoid robot and AI assistant pilot launch constitutes major product innovation with potential to shift company trajectory.

Realbotix Corp. will deploy its first humanoid robot and AI teacher's assistant in a U.S. school district. First humanoid robot deployment in U.S. schools marks major product launch and new market entry for Realbotix.

Realbotix Corp. issued an update on its Nasdaq listing application process and related regulatory steps. Pursuit of a Nasdaq listing represents a major strategic step that can materially improve share liquidity, investor access, and company valuation.

Realbotix Corp. (XBOTF) plans to expand operations into a new facility to support growth. New facility expansion enables scaled production and strengthens competitive positioning.

Onconetix highlights Realbotix's launch of Vinci AI Vision System through delivery of first Vinci-equipped humanoid robot to Ericsson. Launch of Vinci AI Vision System with first delivery to Ericsson signals major product advancement and key customer validation for Realbotix.

Realbotix Corp. (XBOTF) launches AI vision system Vinci alongside delivery of Ericsson robot. Launching Vinci AI vision system with Ericsson robot delivery marks major product innovation enhancing robotics capabilities and market position.

Onconetix announces update on deliveries of Realbotix AI humanoid robots, highlighting progress in the rollout. Delivery update on core AI humanoid robots represents a major milestone advancing product commercialization and investor confidence.

Realbotix Corp. (XBOTF) announced an update on deliveries of its AI humanoid robots. AI humanoid robot delivery update marks a key milestone in commercialization, poised to drive revenue growth and enhance competitive positioning.

Onconetix appoints David White as Chief Executive Officer and Sammy Dorf as member of the Board of Directors. CEO and board appointments constitute major leadership changes that could significantly alter strategic direction and investor sentiment for Realbotix Corp. (XBOTF).

Realbotix Corp. (XBOTF) appoints Susan Pirzchalski as Head of Robotics Engineering. Appointment of a new head for core robotics engineering signals potential improvements in product innovation and technical leadership.

Onconetix highlights Realbotix Corp. (XBOTF)’s role in Ericsson’s world-first 6G trial demonstration. Realbotix’s participation in Ericsson’s pioneering 6G trial signals major strategic advancement in telecom robotics integration.

Ericsson showcased a Realbotix robot in the world's first 6G trial demonstration. Ericsson's selection of Realbotix robot for world-first 6G trial validates its technology and signals major credibility boost in telecom-robotics integration.

Sue Ennis joins Realbotix Corp. (XBOTF) to lead its direct-to-consumer business. Hiring a leader for direct-to-consumer operations targets key growth area in sales and market expansion.

Realbotix Corp. (XBOTF) reported financial results for Q1-2026. Q1 financial results directly impact investor sentiment, stock valuation, and future market performance.

Realbotix Corp. (XBOTF) issued a financial reporting update. Financial reporting updates affect key financial performance metrics and investor sentiment.

Realbotix Corp. (XBOTF) appointed Eric Olsen, an industry-leading robotics veteran, as its new Chief Operating Officer. Appointing an industry-leading robotics veteran as COO strengthens operational leadership and competitive positioning significantly.

Realbotix Corp. has announced the sale of its subsidiary, Realbotix, LLC, to a NASDAQ-listed issuer. This strategic move is expected to enhance Realbotix Corp.'s focus on its core operations and potentially improve its financial standing. The sale of a subsidiary to a NASDAQ-listed issuer indicates a significant strategic shift that could positively impact the company's future performance.

Onconetix has announced its intention to acquire Realbotix LLC, a USA-based company specializing in AI-powered humanoid robotics. This acquisition aims to enhance Onconetix's capabilities in the robotics sector, leveraging Realbotix's innovative technology and expertise. The deal is expected to position Onconetix more competitively in the growing market for humanoid robots and AI applications. The acquisition is a significant strategic move that could enhance Onconetix's competitive position and market presence in the robotics industry.

Realbotix Corp. has announced the sale of its subsidiary, Realbotix, LLC, to Onconetix. This strategic move is part of Realbotix's efforts to streamline operations and focus on core business areas. The transaction is expected to enhance the company's financial position and operational efficiency. The sale of a subsidiary may moderately influence Realbotix's financial performance and operational focus.

Ericsson has deployed a humanoid robot developed by Realbotix Corp. (XBOTF) to enhance workforce and visitor engagement. This initiative aims to improve interactions within the workplace and provide a unique experience for visitors, showcasing the potential of robotics in business environments. The deployment of a humanoid robot for engagement purposes represents a significant strategic move that could enhance Realbotix's market position and investor sentiment.

Realbotix Corp. showcased the first public embedded AI conversation between two humanoid robots at CES 2026, highlighting advancements in robotics and artificial intelligence. This demonstration marks a significant milestone in the company's efforts to integrate AI into humanoid robots, potentially enhancing their interactive capabilities and market appeal. The demonstration of AI conversation between humanoid robots represents a significant advancement in technology that could enhance product offerings and market positioning.

Realbotix Corp. has partnered with FUTR to integrate AI agents into the physical world, aiming to enhance user interaction with advanced AI technologies. This collaboration is expected to leverage Realbotix's expertise in robotics and AI to create more immersive experiences, potentially expanding their market reach and product offerings. The partnership with FUTR represents a significant strategic move that could enhance product innovation and market positioning.

Realbotix Corp. has partnered with FUTR to integrate AI agents into the physical world, aiming to enhance user interaction with AI technology. This collaboration is expected to leverage advancements in artificial intelligence to create more immersive and responsive experiences for users, potentially expanding the market for AI-driven products and services. The partnership represents a significant strategic move that could enhance Realbotix's product offerings and market position.